Western blot analysis of MRC5 further confirmed that the longer the duration of TGFβ treatment, the higher the expression of lung fibrosis markers (including COL1A1 and Vim), but the lower the expression of RTN3 (Fig. 1D). Here, TGFB1 is linked to pulmonary fibrosis.